Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via ACP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via ACP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Online First
Prognostic value of KRAS mutations, TP53 mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Original research
Prognostic value of
KRAS
mutations,
TP53
mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy
Online download statistics by month:
Online download statistics by month: November 2022 to April 2023
Abstract
Full
Pdf
Nov 2022
780
36
20
Dec 2022
384
24
11
Jan 2023
471
10
4
Feb 2023
435
13
5
Mar 2023
137
8
0
Apr 2023
120
6
3
Total
2327
97
43
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via ACP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF